No Data
Erasca's Stable Cash Runway and Upcoming Clinical Milestones Secure Buy Rating
Erasca (ERAS) Receives a Hold From Bank of America Securities
Express News | Erasca Files Prospectus for Proposed Resale or Other Disposition by Selling Securityholders of up to 21.1 Mln Shares of Common Stock - SEC Filing
Erasca Reports Q1 Results
Analysts Offer Insights on Healthcare Companies: Amphastar Pharmaceuticals (AMPH) and Erasca (ERAS)
Express News | HC Wainwright & Co. Reiterates Buy on Erasca, Maintains $8 Price Target